ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Clinical T2 N0 M0 Esophageal Cancer: Identifying Predictive Factors of Upstaging

Thursday, June 27, 2024

Submitted by

Jo Chikwe

Source

Source Name: The Annals of Thoracic Surgery

Source URL: https://www.annalsthoracicsurgery.org/article/S0003-4975(24)00075-4/abstract

Author(s)

Sadia Tasnim, Siva Raja, Eugene H. Blackstone, Andrew J. Toth, John O. Barron, Daniel P. Raymond, Alejandro C. Bribriesco, Dean P. Schraufnagel, Sudish C. Murthy, Monisha Sudarshan

Of 1,579 patients undergoing esophagectomy for esophageal cancer, 60 patients underwent up-front surgery for cT2 N0 M0 esophageal cancer, of whom 8 (13 percent) were found to have pathologic T2 N0 M0, 16 (27 percent) were pathologically downstaged, and 36 (60 percent) were upstaged, 7 (19 percent) on the basis of pathologic T stage, 14 (39 percent) on pathologic N stage, and 15 (42 percent) had upstaging of T and N stages. Dysphagia and high maximum standardized uptake value of the tumor were predictive of more advanced underlying disease.